Massive insulin overdose: Detailed studies of free insulin levels and glucose requirements

References

• Potter J., Clarke P., Gale E., Dave S., Tattersall R. Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg. Brit. Med. J. 1982; 285: 1180–1182
   PubMed Web of Science ®Google Scholar
• Goldgewicht C., Slama G., Papoz L., Tchobroutsky G. Hypoglycaemic reactions in 172 type 1 (insulin-dependent) diabetic patients. Diabetologia 1983; 24: 95–99
   PubMed Web of Science ®Google Scholar
• Muhlhauser I., Berger M., Sonnenberg G., Koch J., Jorgens V., Schernthaner G., Scholz V. Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care 1985; 8: 268–273
   PubMed Web of Science ®Google Scholar
• Arem R., Zoghbi W. Insulin overdose in eight patients: insulin pharmacokinetics and review of the literature. Medicine 1985; 64: 323–332
   PubMed Web of Science ®Google Scholar
• Kuzuya H., Blix P., Horwitz D., Steiner D., Rubenstein A. Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 1977; 26: 22–29
   PubMed Web of Science ®Google Scholar
• Martin F., Hansen N., Warne G. Attempted suicide by insulin overdose in insulin-requiring diabetics. Med. J. Aust. 1977; 1: 58–60
   PubMed Web of Science ®Google Scholar
• Munck O., Quaade F. Suicide attempted with insulin. Dan. Med. Bull. 1963; 10: 139–141
   Google Scholar
• Roy S., Chou M., Field J. Time-action characteristics of regular and NPH insulin in insulin-treated diabetics. J. Clin. Endocrinol. Metab. 1980; 50: 475–479
   PubMed Web of Science ®Google Scholar
• Binder C., Lauritzen T., Faber O., Pramming S. Insulin pharmacokinetics. Diabetes Care 1984; 7: 188–199
   PubMed Web of Science ®Google Scholar
• Kolendorf K., Aaby P., Westergaard S., Deckert T. Absorption, effectiveness and side effects of highly purified porcine NPH-insulin preparations (Leo). Eur. J. Clin. Pharmacol. 1978; 14: 117–124
   PubMed Web of Science ®Google Scholar
• Pramming S., Lauritzen T., Thorsteinsson B., Johansen K., Binder C. Absorption of soluble and isophane semi-synthetic human and porcine insulin in insulin-dependent diabetic subjects. Acta Endocrinol. 1984; 105: 215–220
   PubMedGoogle Scholar
• Lauritzen T., Faber O., Binder C. Variation in I(125)-insulin absorption and blood glucose concentration. Diabetologia 1979; 17: 291–295
   PubMed Web of Science ®Google Scholar
• Deckert T. Intermediate-acting insulin preparations: NPH and Lente. Diabetes Care 1980; 3: 623–626
   PubMed Web of Science ®Google Scholar
• Kolendorf K., Bojsen J. Biotelemetric detection of the disappearance of subcutaneously injected I(125)-NPH insulin. Clinical Physiol. 1982; 2: 13–20
   PubMedGoogle Scholar
• Kolendorf K., Bojsen J. Kinetics of subcutaneous NPH insulin in diabetics. Clin. Pharmacol. Ther. 1982; 31: 494–500
   PubMed Web of Science ®Google Scholar
• Ginsberg S., Block M., Mako M., Rubersten A. Serum insulin levels following administration of exogenous insulin. J. Clin. Endocrinol. Metab. 1973; 36: 1175–1179
   PubMed Web of Science ®Google Scholar
• Dobson H., Robbins L., Johnson P., Mdalel J., Odem D., Cornwall G., Davis M. Absorption of I(131)-labeled modified insulin. Metabolism 1967; 16: 723–732
   Web of Science ®Google Scholar
• Berger M., Cuppers J., Hegner H., Jorgens V., Berchtold P. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care 1982; 5: 77–91
   PubMed Web of Science ®Google Scholar
• Hildebrandt P., Sejrsen P., Nielsen S., Birch K., Sestoft L. Diffusion and polymerization determines the insulin absorption from subcutaneous tissue in diabetic patients. Scand. J. Clin. Lab. Invest. 1985; 45: 685–690
   PubMed Web of Science ®Google Scholar
• Henry D., Lowe J., Citrin D., Manderson W. Defective absorption of injected insulin. Lancet 1978; ii: 741
   Google Scholar
• Kolendorf K., Bojsen J., Deckert T. Clinical factors influencing the absorption of I(125)-insulin in diabetic patients. Horm. Metab. Res. 1983; 15: 274–278
   PubMed Web of Science ®Google Scholar
• Lauritzen T., Pramming S., Gale E., Deckert T., Binder C. Absorption of isophane (NPH) insulin and its clinical implications. Brit. Med. J. 1982; 285: 159–162
   PubMed Web of Science ®Google Scholar
• Sherwin R., Kramer K., Tobin J., Insel P., Liljenquist J., Berman M., Andres R. A model of the kinetics of insulin in man. J. Clin. Invest. 1974; 53: 1481–1492
   PubMed Web of Science ®Google Scholar
• Izzo J., Bartlett J., Roncone A., Izzo M., Bale W. Physiological processes and dynamics in the disposition of small and large doses of biologically active and inactive I(131)-insulins in the rat. J. Biol. Chem. 1967; 242: 2343–2355
   PubMed Web of Science ®Google Scholar
• Silvers A., Swenson R., Farquhar J., Reaven G. Derivation of a three compartment model describing disappearance of plasma insulin-I(131) in man. J. Clin. Invest. 1969; 48: 1461–1469
   PubMed Web of Science ®Google Scholar
• Navalesi R., Pilo A., Ferrannine E. Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. J. Clin. Invest. 1978; 61: 197–208
   PubMed Web of Science ®Google Scholar
• Genuth S. Metabolic clearance of insulin in man. Diabetes 1972; 21: 1003–1012
   PubMed Web of Science ®Google Scholar
• Van Haeften T., Bolli G., Dimitriadis G., Gottesman I., Horwitz D., Gerich J. Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus. Metabolism 1986; 35: 649–656
   PubMed Web of Science ®Google Scholar
• Gardner D., Wilson H., Podet E. Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies. J. Clin. Endocrinol. Metab. 1986; 62: 621–627
   PubMed Web of Science ®Google Scholar
• Rubenstein A., Spitz I. Role of the kidney in insulin metabolism and excretion. Diabetes 1968; 17: 161–169
   PubMed Web of Science ®Google Scholar
• Kleinbaum J., Shamoon H. Impaired counterregulation of hypoglycemia in insulin-dependent diabetes mellitus. Diabetes 1983; 32: 493–498
   PubMed Web of Science ®Google Scholar
• Bolli G., Dimitriadis G., Pehling G., Baker B., Haymond M., Cryer P., Gerich J. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1984; 310: 1706–1711
   PubMed Web of Science ®Google Scholar
• Asplin C., Raghu P., Koerker D., Palmer J. Glucose counterregulation during recovery from neuroglycopenia: which mechanism is important. Metabolism 1985; 34: 15–18
   PubMed Web of Science ®Google Scholar
• Boden G., Reichard G., Hoeldtke R., Rezvani I., Owen O. Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. N. Engl. J. Med. 1981; 305: 1200–1204
   PubMed Web of Science ®Google Scholar
• Adamson U. Impaired counterregulation of hypoglycemia in a group of insulin-dependent diabetics with recurrent episodes of severe hypoglycemia. Acta Med. Scand. 1984; 216: 215–222
   PubMed Web of Science ®Google Scholar
• Lorenzi M., Bohannon N., Tsalikian E., Karam J. Duration of type 1 diabetes affects glucagon and glucose responses to insulin-induced hypoglycemia. West. J. Med. 1984; 141: 467–471
   PubMedGoogle Scholar
• Olefsky J., Kolterman O. Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. Am. J. Med. 1981; 70: 151–168
   PubMed Web of Science ®Google Scholar
• Revers R., Kolterman O., Scarlett J., Gray R., Olefsky J. Lack of in vivo insulin resistance in controlled insulin-dependent, type I, diabetic patients. J. Clin. Endocrinol. Metab. 1984; 58: 353–358
   PubMed Web of Science ®Google Scholar